Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma

Journal of Neurochemistry

Volumn 112, Issue 3, 2010, Pages 611-624

  Paterniti, Irene ^a   Genovese, Tiziana ^a,b   Mazzon, Emanuela ^b   Crisafulli, Concetta ^a   Di Paola, Rosanna ^b   Galuppo, Maria ^a   Bramanti, Placido ^b   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Apoptosis; Cytokines; Nuclear factor kappa B; Spinal cord injury; T0901317

Indexed keywords

CYTOKINE; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; MYELOPEROXIDASE; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BAX; PROTEIN BCL 2; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LAMINECTOMY; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SPINAL CORD INJURY; THORACIC SPINAL CORD; TISSUE INJURY; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BCL-2-ASSOCIATED X PROTEIN; CYTOKINES; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; HYDROCARBONS, FLUORINATED; IN SITU NICK-END LABELING; LAMINECTOMY; LIPID PEROXIDATION; MALE; MICE; MOVEMENT DISORDERS; MYELITIS; NEUTROPHIL INFILTRATION; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; ORPHAN NUCLEAR RECEPTORS; PEROXIDASE; POLY ADENOSINE DIPHOSPHATE RIBOSE; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SPINAL CORD INJURIES; STATISTICS, NONPARAMETRIC; SULFONAMIDES; TIME FACTORS; TYROSINE;

MUS;

EID: 73949087016     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06471.x     Document Type: Article

References (41)

1. Ackery A. et al. (2006) Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. J. Neurotrauma 23, 604 616.
2. Andersson S. et al. (2005) Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice. Proc. Natl Acad. Sci. USA 102, 3857 3862.
3. Bao F. et al. (2003) Peroxynitrite generated in the rat spinal cord induces oxidation and nitration of proteins: reduction by Mn (III) tetrakis (4-benzoic acid) porphyrin. J. Neurosci. Res. 71, 220 227.
4. Bar-Peled O. et al. (1999) Motor neuron degeneration is attenuated in bax-deficient neurons in vitro. J. Neurosci. Res. 55, 542 556.
5. Basso D. M. et al. (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1 21.
6. Beattie M. S. et al. (2000) Review of current evidence for apoptosis after spinal cord injury. J. Neurotrauma 17, 915 925.
7. Beattie M. S. et al. (2002) Cell death in models of spinal cord injury. Prog. Brain Res. 137, 37 47.
8. Bethea J. R. et al. (1998) Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18, 3251 3260.
9. Bowie A. O'Neill L. A. (2000) Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59, 13 23.
10. Casha S. et al. (2001) Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103, 203 218.
11. Castrillo A. et al. (2003) Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278, 10443 10449.
12. Chiarugi A. (2002) Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited Trends Pharmacol. Sci. 23, 122 129.
13. Coleman W. P. et al. (2000) A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J. Spinal Disord. 13, 185 199.
14. Cuzzocrea S. et al. (2006) Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma. J. Pharmacol. Exp. Ther. 319, 127 138.
15. Dosreis G. A. et al. (2004) The central role of Fas-ligand cell signaling in inflammatory lung diseases. J. Cell Mol. Med. 8, 285 293.
16. Genovese T. et al. (2006) Modulation of nitric oxide homeostasis in a mouse model of spinal cord injury. J. Neurosurg. Spine 4, 145 153.
17. Glaser J. et al. (2006) Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury. J. Neurosci. Res. 84, 724 734.
18. Hurlbert R. J. (2000) Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J. Neurosurg. 93, 1 7.
19. Hurlbert R. J. (2006) Strategies of medical intervention in the management of acute spinal cord injury. Spine 31, S16 S21.
20. Joseph S. B. et al. (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9, 213 219.
21. Joshi M. Fehlings M. G. (2002a) Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: part 1. Clip design, behavioral outcomes, and histopathology. J. Neurotrauma 19, 175 190.
22. Joshi M. Fehlings M. G. (2002b) Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J. Neurotrauma 19, 191 203.
23. Kim H. J. et al. (2008) Liver X receptor beta (LXRbeta): a link between beta-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia. Proc. Natl Acad. Sci. USA 105, 2094 2099.
24. Koldamova R. P. et al. (2005) The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J. Biol. Chem. 280, 4079 4088.
25. La Rosa G. et al. (2004) Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats. J. Neurosurg. Spine 1, 311 321.
26. Lacza Z. et al. (2003) PARP inhibition improves the effectiveness of neural stem cell transplantation in experimental brain trauma. Int. J. Mol. Med. 12, 153 159.
27. Morales J. R. et al. (2008) Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke. Circulation 118, 1450 1459.
28. Mullane K. (1989) Neutrophil-platelet interactions and post-ischemic myocardial injury. Prog. Clin. Biol. Res. 301, 39 51.
29. Nesic-Taylor O. et al. (2005) Exogenous Bcl-xL fusion protein spares neurons after spinal cord injury. J. Neurosci. Res. 79, 628 637.
30. Nockels R. Young W. (1992) Pharmacologic strategies in the treatment of experimental spinal cord injury. J. Neurotrauma 9 (Suppl 1 S211 S217.
31. Ohkawa H., Ohishi N. Yagi K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351 358.
32. Riddell D. R. et al. (2007) The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Mol. Cell. Neurosci. 34, 621 628.
33. Samadikuchaksaraei A. (2007) An overview of tissue engineering approaches for management of spinal cord injuries. J. Neuroeng. Rehabil. 4, 15.
34. Sirin B. H. et al. (2002) Ischaemic preconditioning reduces spinal cord injury in transient ischaemia. Acta Cardiol. 57, 279 285.
35. Skaper S. D. (2003) Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection. Ann. N Y Acad. Sci. 993, 217 228.
36. Szabo C. Dawson V. L. (1998) Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci. 19, 287 298.
37. Valledor A. F. Ricote M. (2004) Nuclear receptor signaling in macrophages. Biochem. Pharmacol. 67, 201 212.
38. Verma I. M. (2004) Nuclear factor (NF)-kappaB proteins: therapeutic targets. Ann. Rheum. Dis. 63 (Suppl. 2 ii57 ii61.
39. Wang Y. et al. (2005) Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines. J. Lipid Res. 46, 2377 2387.
40. Yang K D. Shaio M. F. (1994) Hydroxyl radicals as an early signal involved in phorbol ester-induced monocytic differentiation of HL60 cells. Biochem. Biophys. Res. Commun. 200, 1650 1657.
41. Yasuda T. et al. (2005) Suppression of inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 22(R)-hydroxycholesterol requires de novo protein synthesis in activated macrophages. J. Steroid Biochem. Mol. Biol. 97, 376 383.